Adaptive resistance to cefiderocol in carbapenem-resistant Acinetobacter baumannii (CRAB): microbiological and clinical issues

Objectives: Determining the best available therapy for carbapenem-resistant Acinetobacter baumannii (CRAB) infections is a challenge. Cefiderocol is an attractive alternative drug effective against many resistance mechanisms in Gram-negative bacteria. However, its place in the treatment of Acinetoba...

Full description

Bibliographic Details

Published in:	Heliyon
Main Authors:	Anissa Desmoulin, Loïk Sababadichetty, Laure Kamus, Marion Daniel, Lucie Feletti, Nicolas Allou, Anaïs Potron, Anne-Gaëlle Leroy, Marie-Christine Jaffar-Bandjee, Olivier Belmonte, Thomas Garrigos, Guillaume Miltgen
Format:	Article
Language:	English
Published:	Elsevier 2024-05-01
Subjects:	Cefiderocol Adaptive resistance Acinetobacter baumannii Therapeutic decision NDM/OXA carbapenemases
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844024063965